BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35635171)

  • 1. Impact of Primary and Secondary Bile Acids on
    Łukawska A; Mulak A
    Pol J Microbiol; 2022 Mar; 71(1):11-18. PubMed ID: 35635171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut.
    Foley MH; Walker ME; Stewart AK; O'Flaherty S; Gentry EC; Patel S; Beaty VV; Allen G; Pan M; Simpson JB; Perkins C; Vanhoy ME; Dougherty MK; McGill SK; Gulati AS; Dorrestein PC; Baker ES; Redinbo MR; Barrangou R; Theriot CM
    Nat Microbiol; 2023 Apr; 8(4):611-628. PubMed ID: 36914755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
    Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
    J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
    Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
    Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model.
    Li X; Kang Y; Huang Y; Xiao Y; Song L; Lu S; Ren Z
    Biomed Pharmacother; 2021 May; 137():111290. PubMed ID: 33508620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
    Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
    Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbial-derived bile acid lithocholate and its epimers inhibit
    Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
    J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856
    [No Abstract]   [Full Text] [Related]  

  • 11. Review and Commentary on the Importance of Bile Acids in the Life Cycle of Clostridioides difficile in Children and Adults.
    Faden H
    J Pediatric Infect Dis Soc; 2021 May; 10(5):659-664. PubMed ID: 33626138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt metabolism is not the only factor contributing to
    Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
    Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis.
    Grüner N; Mattner J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573273
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Saenz C; Fang Q; Gnanasekaran T; Trammell SAJ; Buijink JA; Pisano P; Wierer M; Moens F; Lengger B; Brejnrod A; Arumugam M
    Microbiol Spectr; 2023 Sep; 11(5):e0393322. PubMed ID: 37750706
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Intestinal Bile Acid 7α-Dehydroxylation by
    Studer N; Desharnais L; Beutler M; Brugiroux S; Terrazos MA; Menin L; Schürch CM; McCoy KD; Kuehne SA; Minton NP; Stecher B; Bernier-Latmani R; Hapfelmeier S
    Front Cell Infect Microbiol; 2016; 6():191. PubMed ID: 28066726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversification of host bile acids by members of the gut microbiota.
    Winston JA; Theriot CM
    Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice.
    Jose S; Mukherjee A; Horrigan O; Setchell KDR; Zhang W; Moreno-Fernandez ME; Andersen H; Sharma D; Haslam DB; Divanovic S; Madan R
    Mucosal Immunol; 2021 Mar; 14(2):500-510. PubMed ID: 32811993
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cheng JKJ; Unnikrishnan M
    Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.